FY2026 EPS Forecast for Colgate-Palmolive Lifted by Analyst

Colgate-Palmolive Company (NYSE:CL – Free Report) – Zacks Research lifted their FY2026 earnings estimates for Colgate-Palmolive in a research report issued to clients and investors on Friday, November 13th. Zacks Research analyst Team now expects that the company will earn $3.91 per share for the year, up from their previous forecast of $3.85. The consensus estimate for Colgate-Palmolive’s current full-year earnings is $3.92 per share. Zacks Research also issued estimates for Colgate-Palmolive’s Q4 2026 earnings at $0.98 EPS, Q1 2027 earnings at $0.97 EPS, Q2 2027 earnings at $1.02 EPS, Q3 2027 earnings at $1.01 EPS, Q4 2027 earnings at $1.06 EPS, FY2027 earnings at $4.06 EPS, Q1 2028 earnings at $1.05 EPS, Q2 2028 earnings at $1.09 EPS, Q3 2028 earnings at $1.10 EPS and FY2028 earnings at $4.38 EPS.

A number of other research analysts have also issued reports on the company. UBS Group boosted their price objective on Colgate-Palmolive from $106.00 to $112.00 and gave the company a “buy” rating in a research report on Monday, November 2nd. Royal Bank Of Canada increased their target price on Colgate-Palmolive from $104.00 to $105.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Jefferies Financial Group reaffirmed a “hold” rating and issued a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Raymond James Financial raised their target price on Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Finally, Barclays boosted their price target on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the company an “equal weight” rating in a report on Tuesday, November 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $101.22.

View Our Latest Analysis on CL

Colgate-Palmolive Stock Up 1.2%

Shares of Colgate-Palmolive stock opened at $100.87 on Monday. The stock has a market capitalization of $80.19 billion, a price-to-earnings ratio of 25.23, a PEG ratio of 4.43 and a beta of 0.31. Colgate-Palmolive has a twelve month low of $75.96 and a twelve month high of $101.81. The company has a current ratio of 0.96, a quick ratio of 0.63 and a debt-to-equity ratio of 11.23. The business’s 50 day simple moving average is $91.18 and its 200-day simple moving average is $90.37.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The company had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th were issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, October 20th. Colgate-Palmolive’s payout ratio is 83.14%.

Insiders Place Their Bets

In related news, COO Panagiotis Tsourapas sold 19,938 shares of the stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total value of $1,968,678.12. Following the completion of the transaction, the chief operating officer directly owned 9,111 shares of the company’s stock, valued at $899,620.14. This represents a 68.64% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider John Hazlin sold 23,376 shares of the firm’s stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total value of $2,317,730.40. Following the completion of the sale, the insider owned 27,021 shares in the company, valued at approximately $2,679,132.15. This represents a 46.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 77,414 shares of company stock worth $7,613,786. 0.43% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Corient Private Wealth LP increased its position in Colgate-Palmolive by 29.0% in the 2nd quarter. Corient Private Wealth LP now owns 639,604 shares of the company’s stock worth $58,639,000 after buying an additional 143,812 shares during the period. Bank of America Corp DE bought a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $567,483,000. Brandywine Financial Group boosted its position in shares of Colgate-Palmolive by 35,612.3% in the first quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock valued at $6,209,000 after acquiring an additional 72,649 shares during the period. Cohen Klingenstein LLC grew its stake in shares of Colgate-Palmolive by 9.0% in the third quarter. Cohen Klingenstein LLC now owns 167,669 shares of the company’s stock worth $14,306,000 after acquiring an additional 13,870 shares during the last quarter. Finally, SEB Asset Management AB acquired a new stake in shares of Colgate-Palmolive in the first quarter worth $91,149,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Top Colgate-Palmolive Stories

These are some of the CL stories that stood out recently:

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Featured Articles

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.